1. Home
  2. LOPE vs SRRK Comparison

LOPE vs SRRK Comparison

Compare LOPE & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOPE
  • SRRK
  • Stock Information
  • Founded
  • LOPE 1949
  • SRRK 2012
  • Country
  • LOPE United States
  • SRRK United States
  • Employees
  • LOPE N/A
  • SRRK N/A
  • Industry
  • LOPE Other Consumer Services
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LOPE Real Estate
  • SRRK Health Care
  • Exchange
  • LOPE Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • LOPE 4.9B
  • SRRK 4.2B
  • IPO Year
  • LOPE 2008
  • SRRK 2018
  • Fundamental
  • Price
  • LOPE $164.11
  • SRRK $43.07
  • Analyst Decision
  • LOPE Buy
  • SRRK Strong Buy
  • Analyst Count
  • LOPE 3
  • SRRK 7
  • Target Price
  • LOPE $179.67
  • SRRK $40.43
  • AVG Volume (30 Days)
  • LOPE 161.8K
  • SRRK 1.2M
  • Earning Date
  • LOPE 02-11-2025
  • SRRK 11-12-2024
  • Dividend Yield
  • LOPE N/A
  • SRRK N/A
  • EPS Growth
  • LOPE 18.90
  • SRRK N/A
  • EPS
  • LOPE 7.64
  • SRRK N/A
  • Revenue
  • LOPE $1,018,713,000.00
  • SRRK N/A
  • Revenue This Year
  • LOPE N/A
  • SRRK N/A
  • Revenue Next Year
  • LOPE $17.52
  • SRRK N/A
  • P/E Ratio
  • LOPE $21.78
  • SRRK N/A
  • Revenue Growth
  • LOPE 8.22
  • SRRK N/A
  • 52 Week Low
  • LOPE $118.48
  • SRRK $6.76
  • 52 Week High
  • LOPE $173.37
  • SRRK $46.19
  • Technical
  • Relative Strength Index (RSI)
  • LOPE 53.72
  • SRRK 69.26
  • Support Level
  • LOPE $164.90
  • SRRK $40.95
  • Resistance Level
  • LOPE $168.88
  • SRRK $44.22
  • Average True Range (ATR)
  • LOPE 3.29
  • SRRK 2.57
  • MACD
  • LOPE -1.11
  • SRRK -0.12
  • Stochastic Oscillator
  • LOPE 27.39
  • SRRK 73.14

About LOPE Grand Canyon Education Inc.

Grand Canyon Education, Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's most significant university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases and certificates across nine colleges both online, on ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Share on Social Networks: